Patent · US Active

TRPV1 antagonists

US7998993B2 · kind B2 · utility

5Cited by

1References

15Claims

0Family size

Assignee

Abbott Laboratories · US

Inventors

Richard J. Perner · Gurnee, US
John R. Koenig · Chicago, US
Stanley DiDomenico · Richmond, US
Erol K. Bayburt · Gurnee, US
Jerome F. Daanen · Racine, US
Arthur Gomtsyan · Vernon Hills, US
Michael E. Kort · Lake Bluff, US
Philip R. Kym · Libertyville, US
Robert G. Schmidt · Waukegan, US
Anil Vasudevan · Union Grove, US
Eric A. Voight · Pleasant Prairie, US

Key dates

Filing date	Oct 23, 2008
Grant date	Aug 16, 2011
Priority date	—
Expiry date	Nov 7, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of formula (I)wherein R1, R2, R4, and W are defined in the description are TRPV 1 antagonists with CNS penetration. Compositions comprising such compounds and methods for treating conditions and disorders using such compounds and compositions are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.